134.60
1.62%
-2.195
Overview
News
Price History
Option Chain
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc. stock is currently priced at $134.60, with a 24-hour trading volume of 1.68M.
It has seen a -1.62% decreased in the last 24 hours and a -8.75% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $137.9 pivot point. If it approaches the $134.2 support level, significant changes may occur.
Agilent Technologies Inc. Stock (A) Financials Data
Agilent Technologies Inc. (A) Revenue 2024
A reported a revenue (TTM) of $6.74 billion for the quarter ending January 31, 2024, a -2.81% decline year-over-year.
Agilent Technologies Inc. (A) Net Income 2024
A net income (TTM) was $1.24 billion for the quarter ending January 31, 2024, a -6.58% decrease year-over-year.
Agilent Technologies Inc. (A) Cash Flow 2024
A recorded a free cash flow (TTM) of $1.65 billion for the quarter ending January 31, 2024, a +55.42% increase year-over-year.
Agilent Technologies Inc. (A) Earnings per Share 2024
A earnings per share (TTM) was $4.20 for the quarter ending January 31, 2024, a -5.19% decline year-over-year.
Agilent Technologies Inc. Stock (A) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Binns Philip | Senior Vice President |
Mar 25 '24 |
Sale |
147.54 |
2,827 |
417,096 |
9,997 |
McMullen Michael R. | CEO and President |
Mar 08 '24 |
Sale |
150.00 |
52,297 |
7,844,550 |
253,909 |
Gonsalves Rodney | V.P., Corporate Controller |
Mar 07 '24 |
Sale |
149.00 |
4,828 |
719,348 |
21,329 |
FIELDS HEIDI | Director |
Mar 05 '24 |
Sale |
144.34 |
1,658 |
239,316 |
54,976 |
Binns Philip | Senior Vice President |
Dec 27 '23 |
Sale |
139.78 |
2,880 |
402,566 |
12,824 |
Gonsalves Rodney | V.P., Corporate Controller |
Dec 18 '23 |
Sale |
137.69 |
1,500 |
206,538 |
26,133 |
Ancher-Jensen Henrik | Sr Vice President |
Dec 15 '23 |
Option Exercise |
111.36 |
11,703 |
1,303,235 |
108,835 |
Ancher-Jensen Henrik | Sr Vice President |
Dec 15 '23 |
Sale |
138.36 |
26,331 |
3,643,157 |
82,504 |
McMullen Michael R. | CEO and President |
Dec 13 '23 |
Option Exercise |
42.12 |
2,751 |
115,872 |
308,957 |
McMullen Michael R. | CEO and President |
Dec 13 '23 |
Sale |
130.00 |
2,751 |
357,630 |
306,206 |
Agilent Technologies Inc. Stock (A) Latest News
Waters (WAT) Boosts Waters Operating Segment With HPLC System
Zacks Investment Research
Agilent (A) is Set for Analytica 2024 With Advanced Products
Zacks Investment Research
Agilent (A) to Bolster DCG Segment With Upcoming Solutions
Zacks Investment Research
Agilent (A) Boosts LSAG Segment With Advanced Dilution System
Zacks Investment Research
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
Zacks Investment Research
Agilent (A) Up 7.6% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
About Agilent Technologies Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has collaboration with the University of Southern California Michelson Center for Convergent Bioscience. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
Cap:
|
Volume (24h):